For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Relay Therapeutics Inc (NASDAQ: RLAY) closed at $3.25 in the last session, down -1.22% from day before closing price of $3.29. In other words, the price has decreased by -$1.22 from its previous closing price. On the day, 2.47 million shares were traded. RLAY stock price reached its highest trading level at $3.36 during the session, while it also had its lowest trading level at $3.175.
Ratios:
We take a closer look at RLAY’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 15.95 and its Current Ratio is at 15.95. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on April 17, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $4.
On September 10, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $10.60 to $16.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 30 ’25 when Rahmer Peter sold 10,739 shares for $3.00 per share. The transaction valued at 32,217 led to the insider holds 390,081 shares of the business.
Rahmer Peter sold 1,364 shares of RLAY for $4,324 on Apr 28 ’25. The insider now owns 400,820 shares after completing the transaction at $3.17 per share. On Apr 30 ’25, another insider, Catinazzo Thomas, who serves as the Chief Financial Officer of the company, sold 12,943 shares for $3.00 each. As a result, the insider received 38,829 and left with 355,376 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 554089216 and an Enterprise Value of -181874992. For the stock, the TTM Price-to-Sale (P/S) ratio is 55.35 while its Price-to-Book (P/B) ratio in mrq is 0.70. Its current Enterprise Value per Revenue stands at -18.175 whereas that against EBITDA is 0.478.
Stock Price History:
The Beta on a monthly basis for RLAY is 1.65, which has changed by -0.5396601 over the last 52 weeks, in comparison to a change of 0.09765589 over the same period for the S&P500. Over the past 52 weeks, RLAY has reached a high of $10.72, while it has fallen to a 52-week low of $1.77. The 50-Day Moving Average of the stock is 6.87%, while the 200-Day Moving Average is calculated to be -37.78%.
Shares Statistics:
According to the various share statistics, RLAY traded on average about 2.34M shares per day over the past 3-months and 2168140 shares per day over the past 10 days. A total of 167.76M shares are outstanding, with a floating share count of 128.50M. Insiders hold about 24.63% of the company’s shares, while institutions hold 77.96% stake in the company. Shares short for RLAY as of 1744675200 were 18364112 with a Short Ratio of 7.86, compared to 1741910400 on 19121771. Therefore, it implies a Short% of Shares Outstanding of 18364112 and a Short% of Float of 13.100000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
